Phenylketonuria Treatment Market Estimated To Flourish At USD 1.02 Billion By 2026 : Grand View Research Inc.
San Francisco, 6 August 2019: The Report Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq, CNSA-001, SYNB1618), By Region (North America, APAC, Europe, MEA), And Segment Forecasts, 2019 – 2026 The global phenylketonuria treatment market size is expected to reach USD 1.02 billion by 2026 registering a CAGR of 11.0%, according to a new report by Grand View Research, Inc. Rising prevalence of PKU across the world and favorable government regulations are the factors expected to spur the market growth over the forecast period. For instance, according to the FDA, in 2018, phenylketonuria affected about 1 in 10,000 to 15,000 people in U.S. Furthermore, according to the Orphanet, it was estimated that 1 in 10,000 newborns in Europe is suffering from PKU. The target disease is highly prevalent in European countries, such as Italy, Ireland, and Turkey. It was estimated that around 1 in 4000 individuals in Turkey...